Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine, Bond University, Qld, Australia, 4229.
BMJ. 2013 Sep 10;347:f3755. doi: 10.1136/bmj.f3755.
To evaluate the completeness of descriptions of non-pharmacological interventions in randomised trials, identify which elements are most frequently missing, and assess whether authors can provide missing details.
Analysis of consecutive sample of randomised trials of non-pharmacological interventions.
All reports of randomised trials of non-pharmacological interventions published in 2009 in six leading general medical journals; 133 trial reports, with 137 interventions, met the inclusion criteria.
Using an eight item checklist, two raters assessed the primary full trial report, plus any reference materials, appendices, or websites. Questions about missing details were emailed to corresponding authors, and relevant items were then reassessed.
Of 137 interventions, only 53 (39%) were adequately described; this was increased to 81 (59%) by using 63 responses from 88 contacted authors. The most frequently missing item was the "intervention materials" (47% complete), but it also improved the most after author response (92% complete). Whereas some authors (27/70) provided materials or further information, other authors (21/70) could not; their reasons included copyright or intellectual property concerns, not having the materials or intervention details, or being unaware of their importance. Although 46 (34%) trial interventions had further information or materials readily available on a website, many were not mentioned in the report, were not freely accessible, or the URL was no longer functioning.
Missing essential information about interventions is a frequent, yet remediable, contributor to the worldwide waste in research funding. If trial reports do not have a sufficient description of interventions, other researchers cannot build on the findings, and clinicians and patients cannot reliably implement useful interventions. Improvement will require action by funders, researchers, and publishers, aided by long term repositories of materials linked to publications.
评估随机试验中非药物干预描述的完整性,确定最常缺失的要素,并评估作者是否能够提供缺失的细节。
对非药物干预随机试验连续样本的分析。
2009 年在六家主要的普通医学期刊上发表的非药物干预随机试验的所有报告;符合纳入标准的 133 项试验报告,共 137 项干预措施。
两名评估员使用八项清单评估了主要的完整试验报告,以及任何参考资料、附录或网站。关于缺失细节的问题通过电子邮件发送给相应的作者,然后重新评估相关项目。
在 137 项干预措施中,只有 53 项(39%)得到了充分描述;通过联系 88 位作者中的 63 位回复,这一比例增加到 81 项(59%)。最常缺失的项目是“干预措施材料”(47%完整),但在作者回复后也有了最大的改进(92%完整)。虽然一些作者(27/70)提供了材料或进一步的信息,但其他作者(21/70)无法提供;他们的原因包括版权或知识产权问题、没有材料或干预措施细节、或不知道其重要性。尽管 46 项(34%)试验干预措施在网站上有进一步的信息或材料,但许多报告中没有提到,或者无法自由获取,或者 URL 不再有效。
干预措施的重要信息缺失是导致全球研究资金浪费的一个常见但可纠正的原因。如果试验报告对干预措施的描述不充分,其他研究人员就无法在此基础上进行研究,临床医生和患者也无法可靠地实施有用的干预措施。改善这种情况需要资金提供者、研究人员和出版商采取行动,并借助长期的材料库来支持出版物。